Skip to main content

Advertisement

SpringerLink
Log in

The prognostic significance of renal dysfunction in patients with chronic systolic heart failure

  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

Renal insufficiency is an independent powerful predictor of morbidity and mortality in a number of cardiovascular disorders. A number of retrospective analyses of large heart failure trials have shown that even mild renal insufficiency has powerful negative predictive power in patients with both mild and severe heart failure. We discuss the available data on the prognostic value of mild renal insufficiency in heart failure, as well as possible mechanisms of this phenomenon. Future research should focus on its possible pathophysiology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Massie BM, Shah NB: Evolving trends in the epidemiological factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997, 133:703–708.

    Article  PubMed  CAS  Google Scholar 

  2. Jaagosild P, Dawson NV, Thomas C, et al.: Outcomes of acute exacerbations of severe congestive heart failure: quality of life, resource use, and survival. Arch Intern Med 1998, 158:1081–1089.

    Article  PubMed  CAS  Google Scholar 

  3. Francis GS, Benedict C, Johnstone DE, et al.: Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990, 82:1724–1729. An early study revealing the prognostic implications of neurohormonal activation in patients with CHF.

    PubMed  CAS  Google Scholar 

  4. Pameshwar J, Keegan J, Sparrow J, et al.: Predictors of prognosis in severe chronic heart failure. Am Heart J 1992, 123:421–426.

    Article  Google Scholar 

  5. Aaronson KD, Schwartz S, Chen, TM, et al.: Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997, 95:2660–2667.

    PubMed  CAS  Google Scholar 

  6. Shulman NB, Ford CE, Hall WD, et al.: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-up Program. Hypertension 1989, 13:S85-S90.

    Google Scholar 

  7. Fried LP, Kronmal RA, Newman AB, et al.: Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998, 279:585–592.

    Article  PubMed  CAS  Google Scholar 

  8. Ruilope LM, Salvetti A, Jamerson K, et al.: Renal function and intensive lowering of blood pressure in the hypertensive subjects of the Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol 2001, 12:218–225.

    PubMed  CAS  Google Scholar 

  9. Szczech LA, Best PJ, Crowley E, et al.: Outcomes of patients with chronic renal insufficiency in the Bypass Angioplasty Revascularization Investigation. Circulation 2002, 105:2253–2258.

    Article  PubMed  CAS  Google Scholar 

  10. Kannel WB, McGee DL: Epidemiology of sudden death: insights from the Framingham study. Cardiol Clin 1985, 15:93–105.

    CAS  Google Scholar 

  11. Culleton BF, Larson MG, Wilson PWF, et al.: Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999, 56:2214–2219.

    Article  PubMed  CAS  Google Scholar 

  12. Kamel WB, Stampfer MJ, Castelli WP, et al.: The prognostic significance of proteinuria. Am Heart J 1984, 108:1347–1352.

    Article  Google Scholar 

  13. Mann JFE, Gerstein HC, Pogue J, et al.: Renal insufficiency as predictor of cardiovascular outcomes and impact of ramipril: the HOPE randomization trial. Ann Intern Med 2001, 134:629–636.

    PubMed  CAS  Google Scholar 

  14. Berton G, Citro T, Palmieri R, et al.: Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 1997, 96:3338–3345.

    PubMed  CAS  Google Scholar 

  15. Leier CV, Boudoulas H: Renal disorders and cardiovascular disease. In Heart Disease, edn 6. Edired by Braunwald E. Philadelphia: WB Saunders; 2001:2280–2297.

    Google Scholar 

  16. Ljungmann S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs 1990, 39:10–21.

    Google Scholar 

  17. Cody RJ, Ljungman S, Covit AB, et al.: Regulation of glomerular filtration in chronic congestive heart failure patients. Kidney Int 1988, 34:361–367.

    PubMed  CAS  Google Scholar 

  18. Davies CE, Kilpatrick JA: Renal circulation in “low output” and “high output” heart failure. Clin Sci 1951, 10:53–63.

    Google Scholar 

  19. Ichikawa I, Pfeffer JM, Pfeffer MA, et al.: Role of angiotensin II in the altered real function of congestive heart failure. Circ Res 1984, 55:669–675.

    PubMed  CAS  Google Scholar 

  20. Dzau V: Renin-angiotensin system and renal circulation in clinical congestive heart failure. Kidney Int 1987, 31:S203-S209.

    Google Scholar 

  21. Sasoshima JI, Izumo S: Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts: critical role of the AT1 receptor subtype. Circ Res 1993, 73:413–423.

    Google Scholar 

  22. Kajstura J, Cigola E, Malhotra A, et al.: Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Card 1997, 29:859–870.

    Article  CAS  Google Scholar 

  23. Schrier RW: Pathogenesis of sodium and water retention in high output and low output cardiac failure, nephritic syndrome, cirrhosis, and pregnancy. N Engl J Med 1988, 319:1065–1072. An excellent review on the formation of edema on a variety of medical conditions.

    Article  PubMed  CAS  Google Scholar 

  24. Anderson RJ, Chun HM, Kluge R, et al.: Hyponatremia: a prospective analysis of its epidemiology and the pathogenic role of vasopressin. Ann Intern Med 1985, 102:164–168.

    PubMed  CAS  Google Scholar 

  25. Lee WH, Parker M: Prognostic importance of sodium and its modification by converting enzyme inhibition in patients with severe chronic heart failure. Circulation 1986, 73:257–267.

    PubMed  CAS  Google Scholar 

  26. Volpe M, Magri P, Raqo MA, et al.: Intrarenal determinants of sodium retention of mild heart failure: effects of angiotensin-converting enzyme inhibition. Hypertension 1997, 30:168–176.

    PubMed  CAS  Google Scholar 

  27. Magri P, Rao MA, Cangianello S, et al.: Early impairment of renal hemodynamic reserve in patients with asymptomatic heart failure is restored by angiotensin II antagonism. Circulation 1998, 98:2849–2854.

    PubMed  CAS  Google Scholar 

  28. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31–41.

    Article  PubMed  CAS  Google Scholar 

  29. Erdmann E, Lechat P, Verkenne P, et al.: Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail 2001, 3:469–479.

    Article  PubMed  CAS  Google Scholar 

  30. Hullege HL, Girbes ARJ, de Kam PJ, et al.: Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 2000, 102:203–210.

    Google Scholar 

  31. Dries DL, Exner DV, Domanski MJ, et al.: The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Card 2000, 35:681–689. A retrospective analysis of the SOLVD database. Even in patients with asymptomatic heart failure, CrCl has a strong negative prognostic implication.

    Article  CAS  Google Scholar 

  32. Bittner V, Weiner DH, Yusef S, et al.: Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular systolic dysfunction. SOLVD investigators. JAMA 1993, 270:1702–1707.

    Article  PubMed  CAS  Google Scholar 

  33. Mahon NG, Blackstone EH, Francis GS, et al.: The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Card 2002, 40:1106–1113. A subgroup analysis from the DIG trial comparing the prognostic value of a 6-minute walk test and estimated CrCl. In this study, CrCl predicted survival independently of functional class.

    Article  CAS  Google Scholar 

  34. Rolin HA, Hall PM, Wei R: Inaccuracy of estimated creatinine clearance for prediction of inothalamate glomerular filtration rate. Am J Kidney Dis 1984, 4:48–54.

    PubMed  Google Scholar 

  35. Kearney MT, Fox KA, Lee AJ, et al.: Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure. J Am Coll Cardiol 2002, 40:1801–1808.

    Article  PubMed  Google Scholar 

  36. Pastan S, Baily J: Dialysis therapy. N Engl J Med 1998, 338:1428–1437.

    Article  PubMed  CAS  Google Scholar 

  37. Burt RJ, Gupta-Burt S, Suki WN, et al.: Reversal of left ventricular dysfunction after renal transplantation. Ann Intern Med 1989, 111:635–640. One of a number studies discussing the reversibility of uremic cardiomyopathy after renal transplantation.

    PubMed  CAS  Google Scholar 

  38. Stevenson KW, Tillisch JH, Hamilton M, et al.: Importance of hemodynamic response to therapy in predicting survival with ejection fraction < 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990, 66:1348–1354.

    Article  PubMed  CAS  Google Scholar 

  39. Gerdes AM, Capasso JM: Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol 1995, 27:849–856.

    Article  PubMed  CAS  Google Scholar 

  40. Tamura K, Takahashi N, Nakatani Y, et al.: Prognostic impact of plasma brain natriuretic peptide for cardiac events in elderly patients with heart failure. Gerontolgy 2001, 47:46–51.

    Article  CAS  Google Scholar 

  41. Maeda, Tsutamoto T, Wada A, et al.: High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Card 2000, 36:1587–1593.

    Article  CAS  Google Scholar 

  42. Kasike BL: Relationship between vascular disease and ageassociated changes in the human kidney. Kidney Int 1987, 31:1153–1159.

    Google Scholar 

  43. Parfrey PS, Foley RN: The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999, 10:1606–1615.

    PubMed  CAS  Google Scholar 

  44. Leithe ME, Margorien RD, Hermiller JB, et al.: Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 1984, 69:57–64.

    PubMed  CAS  Google Scholar 

  45. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991, 325:293–302.

    Article  Google Scholar 

  46. The SOLVD Investigators: Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992, 327:685–691.

    Article  Google Scholar 

  47. Pitt B, Zannad F, Remme WJ, et al.: The effect of Spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709–717.

    Article  PubMed  CAS  Google Scholar 

  48. Badr KF, Ichiwaka II: Pre-renal failure: a deleterious shift from renal compensation to decompensation. N Engl J Med 1988, 319:623–629.

    Article  PubMed  CAS  Google Scholar 

  49. Krumholz HM, Chen YT, Vaccarino V et al.: Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 2000, 85:1110–1113.

    Article  PubMed  CAS  Google Scholar 

  50. Weinfeld MS, Chertow GM, Stevenson LW: Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999, 138:285–290. An important study showing an increase in SCr during aggressive diuretic therapy and intravenous dilator therapy in patients with advanced decompensated heart failure is not necessarily from volume depletion.

    Article  PubMed  CAS  Google Scholar 

  51. Johnson W, Omland T, Hall C, et al.: Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002, 39:1623–1629.

    Article  PubMed  CAS  Google Scholar 

  52. Shannon RP, Libby E, Elahi D, et al.: Impact of acute reduction in chronically elevated left atrial pressure on sodium and water excretion. Ann Thorac Surg 1988, 46:430–437.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Heart Failure Research Unit, Division of Cardiology, The University of Texas Southwestern Medical Center, 6000 Harry Hines Boulevard, NB11.200, 75235-8573, Dallas, TX, USA

    S. Raja Laskar MD & Daniel L. Dries MD, MPH

Authors
  1. S. Raja Laskar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel L. Dries MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laskar, S.R., Dries, D.L. The prognostic significance of renal dysfunction in patients with chronic systolic heart failure. Curr Cardiol Rep 5, 205–210 (2003). https://doi.org/10.1007/s11886-003-0050-z

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-003-0050-z

Keywords

Search

Navigation